oral pharmaceutical composition, low dose oral pharmaceutical composition for chronic administration of delayed treatment of onset or development of a condition pain treatment method in an individual in need of this drug, method of treating a condition in an individual in need of this drug
The present invention relates to an oral pharmaceutical composition, comprising methylglyoxal bis(guanylhydrazone) (MGBG) together with at least one oral pharmaceutically acceptable excipient, for use in the treatment or delaying the onset or development of multiple sclerosis when orally administered to a subject.
